Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection

Author:

Senchyna Fiona1,Murugesan Kanagavel1,Rotunno William2,Nadimpalli Sruti S3,Deresinski Stan4,Banaei Niaz124ORCID

Affiliation:

1. Department of Pathology, Stanford University School of Medicine , Stanford, California , USA

2. Clinical Microbiology Laboratory, Stanford University Medical Center , Palo Alto, California , USA

3. Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine , Stanford, California , USA

4. Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine , Stanford, California , USA

Abstract

Abstract We report a fatal case of New Delhi metallo-β-lactamase (NDM)–producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam plus ceftazidime-avibactam followed by cefiderocol. Acquired resistance was documented phenotypically and mediated through preexisting and acquired mutations. This case highlights the need to rethink optimal treatment for NDM-producing organisms.

Funder

Stanford Department of Pathology

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference19 articles.

1. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing;Bankevich;J Comput Biol,2012

2. Comparative genomics of Enterobacter cloacae complex before and after acquired clinical resistance to ceftazidime-avibactam;Senchyna;Diagn Microbiol Infect Dis,2021

3. CARD 2020: antibiotic resistome surveillance with the Comprehensive Antibiotic Resistance Database;Alcock;Nucleic Acids Res,2020

4. Genetic features leading to reduced susceptibility to aztreonam-avibactam among metallo-beta-lactamase-producing Escherichia coli isolates;Sadek;Antimicrob Agents Chemother,2020

5. Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in China: a report from China CRE-network;Wang;Microbiol Spectr,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Antibacterials;Reactions Weekly;2024-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3